Xcenda President, Kristine Flemister, Featured in FiercePharma

January 28, 2020

Kristine Flemister, President of Xcenda, speaks with FiercePharma on the role of technology in commercialization and is also featured in an article with Lash Group president, Tommy Bramley, on AmerisourceBergen's pursuit of innovation and emerging technologies to help manufacturers bring their therapies to market and support patience access to those therapies.

FIERCEPHARMA VIDEO

The Power of Innovation: How Technology Facilitates Market & Patient Access

FiercePharma sits down with the President of Xcenda, Kristine Flemister, to discuss how technology is helping to commercialize new therapies, develop value propositions and expand market access.
Kristine Flemister, President

Fiercepharma

Digital innovation is leading the charge to better patient outcomes

In this article, Kristine Flemister and Tommy Bramley speaks to AmerisourceBergen’s commitment to pursuing innovation and emerging technologies to help manufacturers bring their therapies to market and support patient access to those therapies through Xcenda and Lash Group.
Read article